Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Corynebacterium ulcerans whole genome sequencing

PROVIDER: PRJNA939168 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23629642_1.fastq.gz	Fastqsanger.gz
	SRR23629642_2.fastq.gz	Fastqsanger.gz
	SRR32974343_1.fastq.gz	Fastqsanger.gz
	SRR32974343_2.fastq.gz	Fastqsanger.gz
	SRR32974344_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Corynebacterium ulcerans

Project description:Corynebacterium ulcerans Genome sequencing

| PRJNA273240 | ENA

Corynebacterium ulcerans RAH1

Project description:Corynebacterium ulcerans RAH1 Genome sequencing

| PRJNA236473 | ENA

Corynebacterium Ulcerans FRC58

Project description:Corynebacterium Ulcerans FRC58 Genome sequencing

| PRJNA222503 | ENA

Project description:Corynebacterium ulcerans

| PRJNA547433 | ENA

Corynebacterium ulcerans strain:210932

Project description:Whole genome sequence of Corynebacterium ulcerans strain 210932

| PRJNA260630 | ENA

Corynebacterium ulcerans strain:05146

Project description:Whole genome sequence of Corynebacterium ulcerans strain 05146

| PRJNA263610 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Corynebacterium ramonii FRC0011 strain:FRC11

Project description:Corynebacterium ulcerans FRC11 genome sequencing project

| PRJNA65541 | ENA

Corynebacterium ulcerans 809

Project description:Corynebacterium ulcerans 809 genome sequencing project

| PRJNA61801 | ENA

Corynebacterium ulcerans strain:210931

Project description:Corynebacterium ulcerans strain:210931 Genome sequencing

| PRJNA260628 | ENA